The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.
That's when it's time to turn to professional services like Massage Envy's Oxygenating Treatment, which delivers oxygen and antioxidants to the skin for a smooth and glowing look. It also requires ...
L1-blocking antibody is now approved for metastatic or locally advanced cutaneous SCC in adults who are not candidates for curative surgery or curative radiation.